Oxidative stress and HPV carcinogenesis

Viruses

Volumn 5, Issue 2, 2013, Pages 708-731

  De Marco, Federico ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer initiation; Cancer progression; Cancer promotion; DNA damage; HPV; Oxidative DNA adducts; Oxidative stress; RNS; ROS; Viral carcinogenesis

Indexed keywords

ALDEHYDE OXIDASE; ASCORBIC ACID; CISPLATIN; CYTOCHROME P450; ETOPOSIDE; FERRITIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN E7; PYRUVATE KINASE; REACTIVE NITROGEN SPECIES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; VASCULOTROPIN; XANTHINE OXIDASE;

APOPTOSIS; CANCER GROWTH; CANCER RISK; CONCENTRATION RESPONSE; DNA ADDUCT; DNA DAMAGE; DNA POLYMORPHISM; DRUG EFFICACY; ENZYME ACTIVITY; FATTY ACID OXIDATION; FERRITIN BLOOD LEVEL; GENE AMPLIFICATION; GENE FUNCTION; HUMAN; INFLAMMATION; MITOCHONDRIAL RESPIRATION; ONCOGENE; OXIDATIVE STRESS; PAPILLOMAVIRUS INFECTION; PRDX3 GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; RISK FACTOR; SMOKING; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS REPLICATION;

CELL TRANSFORMATION, VIRAL; FEMALE; HUMANS; OXIDATIVE STRESS; PAPILLOMAVIRIDAE; REACTIVE NITROGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84874041648     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5020708     Document Type: Review

References (122)

1. Zur Hausen, H. Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer 2002, 2, 342-350.
2. Zur Hausen, H. Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin. Cancer Biol. 1999, 9, 405-411.
3. Federico, A.; Morgillo, F.; Tuccillo, C.; Ciardiello, F.; Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer. 2007, 121, 2381-2386.
4. Harrison, D.G.; Widder, J.; Grumbach, I.; Chen, W.; Weber, M.; Searles, C. Endothelial mechano-transduction, nitric oxide and vascular inflammation. J. Intern. Med. 2006, 259, 351-363.
5. Darley-Usmar, V.; Halliwell, B. Blood radicals: Reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm. Res. 1996, 13, 649-662.
6. Zangar, R.C.; Davydov, D.R.; Verma, S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 2004, 199, 316-331.
7. Darr, D.; Fridovich, I. Free radicals in cutaneous biology. J. Invest. Dermatol. 1994, 102, 671-675.
8. Jurkiewicz, B.A.; Buettner, G.R. Ultraviolet light-induced free radical formation in skin: An electron paramagnetic resonance study. Photochem. Photobiol. 1994, 59, 1-4.
9. Riley, P.A. Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int. J. Radia.t Biol. 1994, 65, 27-33.
10. Breimer, L.H. Repair of DNA damage induced by reactive oxygen species. Free Radic. Res. Commun. 1991, 14, 159-171.
11. Ananthaswamy, H.N.; Pierceall, W.E. Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem. Photobiol. 1990, 52, 1119-1136.
12. Danno, K.; Horio, T.; Takigawa, M.; Imamura, S. Role of oxygen intermediates in UV-induced epidermal cell injury. J. Invest. Dermatol. 1984, 83, 166-168.
13. Miyachi, Y. Photoaging from an oxidative standpoint. J. Dermatol. Sci. 1995, 9, 79-86.
14. Dröge, W. Free radicals in the physiological control of cell function. Physiol Rev. 2002, 82, 47-95.
15. Hensley, K.; Robinson, K.A.; Gabbita, S.P.; Salsman, S.; Floyd, R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 2000, 28, 1456-6142.
16. Thannickal, V.J.; Fanburg, B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279, L1005-1028.
17. Lenaz, G.; Genova, M.L. Supramolecular organisation of the mitochondrial respiratory chain: A new challenge for the mechanism and control of oxidative phosphorylation. Adv. Exp. Med. Biol. 2012, 748, 107-144.
18. Dröse, S.; Brandt, U. Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv. Exp. Med. Biol. 2012, 748, 145-169.
19. Di Mascio, P.; Briviba, K.; Bechara, E.J.; Medeiros, M.H.; Sies, H. Reaction of peroxynitrite and hydrogen peroxide to produce singlet molecular oxygen (1deltag). Methods Enzymol. 1996, 269, 395-400.
20. van Asbeck, B.S. Oxygen toxicity: Role of hydrogen peroxide and iron. Adv. Exp. Med. Biol. 1990, 264, 235-246.
21. Bartsch, H.; Nair, J. Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect. Prev. 2004, 28, 385-391.
22. Moriya, M.; Pandya, G.A.; Johnson, F.; Grollman, A.P. Cellular response to exocyclic DNA adducts. IARC Sci. Publ. 1999, 150, 263-270.
23. Martínez-Ruiz, A.; Cadenas, S.; Lamas, S. Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. Free Radic. Biol. Med. 2011, 51, 17-29.
24. Ascenzi, P.; di Masi, A.; Sciorati, C.; Clementi, E. Peroxynitrite-An ugly biofactor? Biofactors. 2010, 36, 264-273.
25. Dansen, T.B.; Wirtz, K.W. The peroxisome in oxidative stress. IUBMB Life 2001, 51, 223-230.
26. Kasai, H.; Okada, Y.; Nishimura, S.; Rao, M.S.; Reddy J.K. Formation of 8-hydroxy deoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res. 1989, 49, 2603-2605.
27. Oikawa, I.; Novikoff, P.M. Catalase-negative peroxisomes: Transient appearance in rat hepatocytes during liver regeneration after partial hepatectomy. Am. J. Pathol. 1995, 146, 673-687.
28. Beckman, K.B.; Ames, B.N. The free radical theory of aging matures. Physiol. Rev. 1998, 78, 547-581.
29. Goeptar, A.R; Scheerens, H.; Vermulen, N.P. Oxygen and xenobiotic reductase activities of cytochrome P450. Crit. Rev. Toxicol. 1995, 25, 25-65.
30. Koop, D.R. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 1992, 6, 724-730.
31. Hussain, S.P.; Hofseth, L.J.; Harris, C.C. Radical causes of cancer. Nat. Rev. Cancer. 2003, 4, 276-285.
32. Ohshima, H.; Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat. Res. 1994, 305, 253-264.
33. Bylund J.; Brown, K.L.; Movitz, C.; Dahlgren, C.; Karlsson, A. Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for? Free Radic. Biol. Med. 2010, 49, 1834-1845.
34. Li, C.; Jackson, R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 2002, 282, C227-241.
35. Kayyali, U.; Donaldson, C.; Huang, H.; Abdelnour, R.; Hassoun, P. Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J. Biol. Chem. 2001, 276, 14359-14365.
36. Plateel, M.; Dehouck, M.P.; Torpier, G.; Cecchelli, R; Teissier, E. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J. Neurochem. 1995, 65, 2138-2145.
37. Al-Mehdi, A.B; Zhao, G.; Dodia, C.; Tozawa, K; Costa, K.; Muzykantov, V.; Ross, C.; Blecha F.; Dinauer, M.; Fisher, A.B. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res. 1998, 83, 730-737.
38. Lenaz, G. Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv. Exp. Med. Biol. 2012, 942, 93-136.
39. Wu, W.S. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 2006, 25, 695-705.
40. Greer, S.N.; Metcalf, J.L.; Wang, Y.; Ohh, M. The updated biology of hypoxia-inducible factor. EMBO J. 2012, 31, 2448-60.
41. Ma, Q. Transcriptional responses to oxidative stress: Pathological and toxicological implications. Pharmacol Ther. 2010, 125, 376-393.
42. Cadet, J.; Loft, S.; Olinski, R.; Evans, M.D.; Bialkowski, K.; Richard Wagner, J.; Dedon, P.C.; Møller, P.; Greenberg, M.M.; Cooke, M.S. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic. Res. 2012, 46, 367-381.
43. Himmelstein, M.W.; Boogaard, P.J.; Cadet, J.; Farmer, P.B.; Kim, J.H.; Martin, E.A.; Persaud, R.; Shuker, D.E. Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage. Crit. Rev. Toxicol. 2009, 39, 679-694.
44. Pilger, A.; Rüdiger, H.W. 8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int. Arch. Occup. Environ. Health 2006, 80, 1-15.
45. Revich, G.G.; Beattie, K.L. Utilization of 1,N6-etheno-2′-deoxyadenosine 5′-triphosphate during DNA synthesis on natural templates, catalyzed by DNA polymerase I of Escherichia coli. Carcinogenesis 1986, 7, 1569-1576.
46. Kamiya, H.; Kasai, H. 2-Hydroxy-dATP is incorporated opposite G by Escherichia coli DNA polymerase III resulting in high mutagenicity. Nucleic Acids Res. 2000, 28, 1640-1646.
47. Levine, R.L.; Yang, I.Y.; Hossain, M.; Pandya, G.A.; Grollman, A.P.; Moriya, M. Mutagenesis induced by a single 1,N6-ethenodeoxyadenosine adduct in human cells. Cancer Res. 2000, 60, 4098-4104.
48. Pandya, G.A.; Moriya, M. 1,N6-ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. Biochemistry 1996, 35, 11487114-11487192.
49. Moriya, M.; Zhang, W.; Johnson, F.; Grollman, A.P. Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. USA 1994, 91, 11899-11903.
50. Esterbauer, H.; Eckl, P.; Ortner, A. Possible mutagens derived from lipids and lipid precursors. Mutat Res. 1990, 238, 223-233.
51. Tudek, B.; Winczura, A.; Janik, J.; Siomek, A.; Foksinski, M.; Oliński, R. Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am. J. Transl. Res. 2010, 2, 254-284
52. Stadtman, E.R.; Levine, R.L. Protein oxidation. Ann. NY Acad. Sci. 2000, 899, 191-208.
53. Butterfield, D.A. Oxidative stress in neurodegenerative disorders. Antioxid. Redox. Signal. 2006, 8, 1971-1973.
54. Butterfield, D.A.; Keller, J.N. Antioxidants and antioxidant treatment in disease. Biochem. Biophys. Acta. 2012, 1822, 615; doi: 10.1016/j.bbadis.2012.02.020.
55. England, K.; Cotter, T.G. Direct oxidative modifications of signaling proteins in mammalian cells and their effects on apoptosis. Redox Rep. 2005, 10, 237-245.
56. De Marco, F.; Bucaj, E.; Foppoli, C.; Fiorini, A.; Blarzino, C.; Filipi, K.; Giorgi, A.; Schininà, M.E.; di Domenico, F.; Coccia, R.; Butterfield, D.A.; Perluigi, M. Oxidative stress in HPV-Driven viral carcinogenesis: Redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS One. 2012, 7, e34366.
57. Morgan, M.J.; Liu, Z.G. Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol. Cells. 2010, 30, 1-12.
58. Taguchi, K.; Motohashi, H.; Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells. 2011, 16, 123-140; doi: 10.1111/j.1365-2443.2010.01473.x
59. Brigelius-Flohé, R.; Flohé, L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal. 2011, 15, 2335-2381.
60. Flohe, L.; Brigelius-Flohe, R.; Saliou, C.; Traber, M.G.; Packer, L. Redox regulation of NF-kappa Bactivation. Free Radic. Biol. Med. 1997, 22, 1115-1126.
61. Aslund, F.; Zheng, M.; Beckwith, J.; Storz, G. Regulation of the OxyR transcription factor by hydrogen peroxide and the cellular thiol-disulfide status. Proc. Natl. Acad. Sci. USA 1999, 96, 6161-6165.
62. Finkel, T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011, 194, 7-15.
63. Fernandez, C.; Sharrard, R.M.; Talbot, M.; Reed, B.D.; Monks, N. Evaluation of the significance of polyamines and their oxidases in the aetiology of human cervical carcinoma. Br. J. Cancer 1995, 72, 1194-1199.
64. Siegel, E.M.; Patel, N.; Lu, B.; Lee, J.H.; Nyitray, A.G.; Huang, X.; Villa L.L.; Franco, E.L.; Giuliano, A.R. Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection. Cancer Epidemiol. Biomarkers Prev. 2012, 21, 859-865.
65. Safaeian, M.; Hildesheim, A.; Gonzalez P.; Yu, K.; Porras, C.; Li, Q.; Rodriguez, A.C.; Sherman, M.E.; Schiffman, M.; Wacholder, S., et al. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. PLoS One 2012, 7, e33619.
66. Conway, M.J.; Alam, S.; Ryndock, E.J.; Cruz, L.; Christensen, N.D.; Roden, R.B.; Meyers, C. Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J Virol. 2009, 83, 10515-10126; doi: 10.1128/JVI.00731-09.
67. Schmitt, J.; Schlehofer, J.R.; Mergener, K.; Gissmann, L.; Zur Hausen H. Amplification of bovine papillomavirus DNA by N-methyl-N'-nitro-N-nitrosoguanidine, ultraviolet irradiation, or infection with herpes simplex virus. Virology 1989, 172, 73-81.
68. Boner, W.; Taylor, E.R.; Tsirimonaki, E.; Yamane, K.; Campo, M.S.; Morgan, I.M. A functional interaction between the HPV16 E2 transcription/replication factor E2 and the DNA damage response protein TopBP1. J. Biol. Chem. 2002, 277, 22297-22303.
69. Achanta, G.; Huang P. Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res. 2004, 64, 6233-6239.
70. Giampieri, S.; Storey, A. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br. J. Cancer. 2004, 90, 2203-2209.
71. Moody, C.A.; Laimins, L.A. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 2009, 5, e1000605; doi: 10.1371/journal.ppat.1000605.
72. Spardy, N.; Covella, K.; Cha, E.; Hoskins, E.E.; Wells, S.I.; Duensing, A.; Duensing, S. Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. Cancer Res. 2009, 69, 7022-7029.
73. King, L.E.; Fisk, J.C.; Dornan, E.S.; Donaldson, M.M.; Melendy, T.; Morgan, I.M. Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling. Virology 2010, 406, 95-102.
74. Mincheva, A.; Gissmann, L.; Zur Hausen, H. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med. Microbiol. Immunol. 1987, 176, 245-256.
75. Heller, A. Apoptosis-inducing high •NO concentrations are not sustained either in nascent or in developed cancers. Chem. Med. Chem. 2008, 3, 1493-1499.
76. Goldstein, S.; Merényi, G. The chemistry of peroxynitrite: implications for biological activity. Methods Enzymol. 2008, 436, 49-61.
77. Dulak, J.; Józkowicz, A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox. Signal. 2003, 5, 123-132.
78. Morbidelli, L.; Donnini, S.; Ziche, M. Role of nitric oxide in tumor angiogenesis. Cancer Treat. Res. 2004, 117, 155-167.
79. Mazibrada, J.; Rittà, M.; Mondini, M.; De Andrea, M.; Azzimonti, B.; Borgogna, C.; Ciotti, M.; Orlando, A.; Surico, N.; Chiusa, L., et al. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol. Oncol. 2008, 108, 112-120.
80. De Marco, F.; Bucaj, E.; Foppoli, C.; Fiorini, A.; Blarzino, C.; Filipi, K.; Giorgi, A.; Schininà, M.E.; Di Domenico, F.; Coccia, R., et al. Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS One 2012, 7, e34366.
81. Vodovot, Y.; Bogdan, C.; Paik, J.; Xie, Q.W.; Nathan, C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 1993, 178, 605-613.
82. Mitani, T.; Terashima, M.; Yoshimura, H.; Nariai, Y.; Tanigawa, Y. TGF-β1 enhances degradation of IFN-γ-induced iNOS protein via proteasomes in RAW 264.7 cells. Nitric. Oxide 2005, 13, 78-87.
83. Baritaki, S.; Sifakis, S.; Huerta-Yepez, S.; Neonakis, I.K.; Soufla, G.; Bonavida, B.; Spandidos, D.A. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: Implication of YY1 in cervical tumorigenesis and HPV infection. Int. J. Oncol. 2007, 31, 69-79.
84. Thomas, D.D.; Liu, X.; Kantrow, S.P.; Lancaster, J.R., Jr. The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc. Natl. Acad. Sci. USA 2001, 8, 355-360.
85. López-Ocejo, O.; Viloria-Petit, A.; Bequet-Romero, M.; Mukhopadhyay, D.; Rak, J.; Kerbel R.S. Oncogenes and tumor angiogenesis: The HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 2000, 19, 4611-4620.
86. Butz, K.; Shahabeddin, L.; Geise, C.; Spitkovsky, D.; Ullmann, A.; Hoppe-Seyler, F. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 1995, 10, 927-933.
87. Butz, K., Whitaker, N.; Denk, C.; Ullmann, A.; Geisen, C.; Hoppe-Seyler, F. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Oncogene 1999, 18, 2381-2386.
88. Ding, B.; Chi, S.G.; Kim, S.H.; Kang, S.; Cho, J.H.; Kim, D.S.; Cho, N.H. Role of p53 in antioxidant defence of HPV-positive cervical carcinoma cells following H2O2 exposure. J. Cell. Sci. 2007, 120, 2284-2294.
89. De Marco, F.; Marcante, M.L. HPV-16 E6-E7 differential transcription induced in Siha cervical cancer cell line by interferons. J. Biol. Regul. Homeost. Agents 1993, 7, 15-21.
90. Abdulkarim, B.; Sabri, S.; Deutsch, E.; Chagraoui, H.; Maggiorella, L.; Thierry, J.; Eschwege, F.; Vainchenker, W.; Chouaïb, S.; Bourhis, J. Antiviral agent Cidofovir restores p53 function and enhances the radio-sensitivity in HPV-associated cancers. Oncogene 2002, 21, 2334-2346.
91. Divya, C.S.; Pillai, M.R. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol. Carcinog. 2006, 45, 320-332.
92. Munagala, R.; Kausar, H.; Munjal, C.; Gupta, R.C. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis 2011, 32, 1697-1705.
93. De Marco, F.; Perluigi, M.; Foppoli, C.; Blarzino, C.; Cini, C.; Coccia, R.; Venuti, A. UVB irradiation down-regulates HPV-16 RNA expression: Implications for malignant progression of transformed cells. Virus Res. 2007, 130, 249-259.
94. Mouret, S.; Sauvaigo, S.; Peinnequin, A.; Favier, A.; Beani, J.C.; Leccia, M.T. E6* oncoprotein expression of human papillomavirus type-16 determines different ultraviolet sensitivity related to glutathione and glutathione peroxidase antioxidant defence. Exp. Dermatol. 2005, 14, 401-410.
95. Shim, J.H.; Kim, K.H.; Cho, Y.S.; Choi, H.S.; Song, E.Y.; Myung, P.K.; Kang, J.S.; Suh, S.K.; Park, S.N.; Yoon, D.Y. Protective effect of oxidative stress in HaCaT keratinocytes expressing E7 oncogene. Amino Acids. 2008, 34, 135-141.
96. Mileo, A.M.; Abbruzzese, C.; Mattarocci, S.; Bellacchio, E.; Pisano, P.; Federico, A.; Maresca, V.; Picardo, M.; Giorgi, A.; Maras, B.; Schininà, M.E.; Paggi, M.G. Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival. PLoS One 2009, 13, e7254.
97. Graham, S.V. Human papillomavirus: Gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol. 2010, 5, 1493-1506; doi: 10.2217/fmb.10.107.
98. Rösl, F.; Das, B.C.; Lengert, M.; Geletneky, K.; Zur Hausen, H. Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J. Virol. 1997, 71, 362-370.
99. Soto, U.; Denk, C.; Finzer, P.; Hutter, K.J.; Zur Hausen, H.; Rösl, F. Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition. Int. J. Cancer. 2000, 86, 811-817.
100. Soto, U.; Das, B.C.; Lengert, M.; Finzer, P.; Zur Hausen, H.; Rösl, F. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene 1999, 18, 3187-3198.
101. Prusty, B.K.; Das, B.C. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int. J. Cancer. 2005, 113, 951-960.
102. Warburg, O. On the origin of cancer cells. Science 1956, 123, 309-314.
103. Zwerschke, W.; Mazurek, S.; Massimi, P.; Banks, L.; Eigenbrodt, E.; Jansen-Dürr, P. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 1999, 96, 1291-1296.
104. Mazurek, S.; Zwerschke, W.; Jansen-Dürr, P.; Eigenbrodt, E. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: Role of pyruvate kinase type M2 and the glycolytic-enzyme complex. Biochem. J. 2001, 356, 247-256.
105. Reshkin, S.J.; Bellizzi, A.; Caldeira, S.; Albarani, V.; Malanchi, I.; Poignee, M.; Alunni-Fabbroni, M.; Casavola, V.; Tommasino, M. Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 2000, 14, 2185-2197.
106. Zur Hausen, H. Human papilloma viruses and their possible role in squamous cell carcinomas. Curr. Top. Microbiol. Immunol. 1977, 78, 1-30.
107. Slater, T.F.; Bajardi, F.; Benedetto, C.; Bussolati, G.; Cianfano, S.; Dianzani, M.U.; Ghiringhello, B.; Nöhammer, G.; Rojanapo, W.; Schauenstein, E.; Protein thiols in normal and neoplastic human uterine cervix. FEBS Lett. 1985, 187, 267-271.
108. Kwasniewska, A.; Gozdzicka-Józefiak, A.; Borzecki, A.; Baranowski, W. DNA adducts in squamous cell cervical carcinomas associated with HPV infection. Eur. J. Gynaec. Oncol. 2003, 3, 359-361.
109. Sgambato, A.; Zannoni, G.F.; Faraglia, B.; Camerini, A.; Tarquini, E.; Spada, D.; Cittadini, A. Decreased expression of the CDK inhibitor p27Kip1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis. Gynecol. Oncol. 2004, 92, 776-783.
110. Hedley, D.; Pintilie, M.; Woo, J.; Nicklee, T.; Morrison, A.; Birle, D.; Fyles, A.; Milosevic, M.; Hill, R. Up-regulation of the redox mediators thioredoxin and apurinic/apyrimidinic excision (APE)/Ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis. Am. J. Pathol. 2004, 164, 557-565.
111. Del Nonno, F.; Pisani, G.; Visca, P.; Signore, F.; Grillo, L.R.; Baiocchini, A.; Garbuglia, A.R.; Sepe, S.; Piacentini, M.; Falasca, L. Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix. Mod. Pathol. 2011, 24, 855-865.
112. Li, L.Q.; Chen, C.L.; Cao, Z.Y.; Liao, Q.P.; Du, H.J.; Zhan, S.B.; Zhou, L.; Zeng, Y. Expression of peroxiredoxin III in cervical lesions. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009, 23, 443-445.
113. Perluigi, M.; Giorgi, A.; Blarzino, C.; De Marco, F.; Foppoli, C.; Di Domenico, F.; Butterfield, D.A.; Schininà, M.E.; Cini, C.; Coccia, R. Proteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation. J. Cell Mol. Med. 2009, 13, 1809-1822.
114. Carrero, Y.; Callejas, D.; Alaña, F.; Silva, C.; Mindiola, R.; Mosquera, J. Increased vascular endothelial growth factor expression, CD3-positive cell infiltration, and oxidative stress in premalignant lesions of the cervix. Cancer 2009, 115, 3680-3688.
115. Maldonado, P.; Negrini, L.A.; Kaizer, R.R.; Zanin, R.F.; Araújo Mdo, C.; Battisti, V.; Morsch, V.M.; Schetinger, M.R. Oxidative status in patients submitted to conization and radiation treatments for uterine cervix neoplasia. Clin. Chim. Acta. 2006, 366, 174-178.
116. Sharma, A.; Rajappa, M.; Satyam, A.; Sharma, M. Oxidant/anti-oxidant dynamics in patients with advanced cervical cancer: correlation with treatment response. Mol. Cell. Biochem. 2010, 341, 65-72.
117. Weitmann, H.D.; Gustorff, B.; Vaupel, P.; Knocke, T.H.; Pötter, R. Oxygenation status of cervical carcinomas before and during spinal anesthesia for application of brachytherapy. Strahlenther Onkol. 2003, 179, 633-640.
118. Ho, G.Y.; Kadish, A.S.; Burk, R.D.; Basu, J.; Palan, P.R.; Mikhail, M.; Romney, S.L. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int. J. Cancer 1998, 78, 281-285.
119. Ho, G.Y.; Palan, P.R.; Basu, J.; Romney, S.L.; Kadish, A.S.; Mikhail, M.; Wassertheil-Smoller, S.; Runowicz, C.; Burk, R.D. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int. J. Cancer. 1998, 78, 594-599.
120. Alam, S.; Conway, M.J.; Chen, H.S.; Meyers, C. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J. Virol. 2008, 82, 1053-1058.
121. Reddy, V.G.; Khanna, N.; Singh N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. Biochem. Biophys. Res. Commun. 2001, 282, 409-415.
122. López, J.; Poitevin, A.; Mendoza-Martínez, V.; Pérez-Plasencia, C.; García-Carrancá, A.; Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer, 2012, 28, 12-48.